Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

FDA reiterates guidance plans on distributed and point-of-care manufacturing (from Catapult’s regulatory round-up – November 2023)

The FDA has reiterated its plan to issue draft guidance spelling out how it intends to regulate distributed manufacturing (DM) and point-of-care (POC) manufacturing of drugs and biologics. FDA expects that issuing such guidance may clear up regulatory ambiguities and spur the adoption of these technologies. Please find further details here.

Published on the 5th of december 2023. Read Catapult’s entire regulatory round-up here.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (21 mai 2024). FDA reiterates guidance plans on distributed and point-of-care manufacturing (from Catapult’s regulatory round-up – November 2023). ELSIBI. Consulté le 16 décembre 2025 à l’adresse https://doi.org/10.58079/11p09


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.